Catelani Michael has filed 6 insider transactions across 1 company since January 2024.
Most recent transaction: a grant/award of 175000 shares of Anixa Biosciences Inc ($ANIX) on January 05, 2026.
Activity breakdown: 2 open-market purchases and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 5, 2026 | Anixa Biosciences Inc | $ANIX | Catelani Michael | President, COO & CFO | A | Employee Stock Option | 175000 | $0.00 | 175,000.0000 | 32,916,915 | 9999.99% | 0.53% |
| Jan. 15, 2025 | Anixa Biosciences Inc | $ANIX | Catelani Michael | President, COO, & CFO | P | Common Stock | 9289 | $2.15 | 44,500.0000 | 0 | 26.38% | 0.00% |
| Jan. 2, 2025 | Anixa Biosciences Inc | $ANIX | Catelani Michael | President, COO & CFO | A | Employee Stock Option | 350000 | $0.00 | 350,000.0000 | 0 | 9999.99% | 0.00% |
| June 7, 2024 | Anixa Biosciences Inc | $ANIX | Catelani Michael | President, COO, & CFO | P | Common Stock | 6250 | $2.40 | 35,211.0000 | 0 | 21.58% | 0.00% |
| April 30, 2024 | Anixa Biosciences Inc | $ANIX | Catelani Michael | President, COO, & CFO | A | Common Stock | 1189 | $2.52 | 28,961.0000 | 0 | 4.28% | 0.00% |
| Jan. 12, 2024 | Anixa Biosciences Inc | $ANIX | Catelani Michael | President, COO & CFO | A | Employee Stock Option (Right to Buy) | 350000 | $0.00 | 350,000.0000 | 0 | 9999.99% | 0.00% |